See
Genome Information for Plasmodium falciparum
Plasmodium falciparum clinical isolates collected from patients diagnosed with malaria at health facilities in Bobo-Dioulasso in 2021 and 2022. Ex vivo drug sensitivity data was generated for these isolates.
| Accession | PRJNA1067191 |
| Data Type | Raw sequence reads |
| Scope | Multiisolate |
| Organism | Plasmodium falciparum[Taxonomy ID: 5833] Eukaryota; Sar; Alveolata; Apicomplexa; Aconoidasida; Haemosporida; Plasmodiidae; Plasmodium; Plasmodium (Laverania); Plasmodium falciparum |
| Grants | - "Resistance of Malaria Parasites to Artemisinin-Based Combination Therapies in Uganda" (Grant ID R01 AI075045, National Institute of Allergy and Infectious Diseases Extramural Activities)
- "Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline" (Grant ID R01 AI139179, National Institute of Allergy and Infectious Diseases Extramural Activities)
|
| Submission | Registration date: 21-Jan-2024
University of California, San Francisco |
| Relevance | Medical |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 449 |
| Other datasets |
| BioSample | 279 |